Why did nesiritide use decline?

The ASCEND-HF trial (2011, n=7,141) definitively showed that nesiritide did not reduce 30-day mortality or heart failure rehospitalization despite improving dyspnea symptoms. Combined with significant hypotension risk and the availability of effective diuretic therapy, most clinicians have moved away from routine nesiritide use.

Is nesiritide still available?

Nesiritide (Natrecor) remains FDA-approved but is rarely used in current clinical practice. It is still mentioned in heart failure guidelines as a potential adjunct for hemodynamic support in acute decompensated heart failure refractory to standard therapy.

What is the difference between nesiritide and sacubitril?

Nesiritide is exogenous recombinant BNP given IV for acute heart failure. Sacubitril (part of Entresto/sacubitril-valsartan) is a neprilysin inhibitor that prevents breakdown of endogenous natriuretic peptides, given orally for chronic heart failure with reduced ejection fraction. They both work through the natriuretic peptide pathway but with different approaches and clinical settings.

What is the recommended dose range for Nesiritide?

The research dose range is 2 mcg/kg IV bolus followed by 0.01 mcg/kg/min continuous infusion, administered via Intravenous infusion, Continuous (up to 48 hours).

peptide dosing

Nesiritide Dosing & Reconstitution Guide

Complete dosing reference for Nesiritide (Cardiovascular / Natriuretic). Covers reconstitution, dose range, titration schedule, pharmacokinetics, and storage protocols for research use.

Dosing Protocol

Route: Intravenous infusion Frequency: Continuous (up to 48 hours) Dose Range: 2 mcg/kg IV bolus followed by 0.01 mcg/kg/min continuous infusion

Safety & Contraindications

Safety: Hypotension is the most common adverse effect (dose-dependent); occurred in 11% vs 4% with nitroglycerin in VMAC ASCEND-HF showed significantly more symptomatic hypotension with nesiritide vs placebo (26.6% vs 15.3%, p<0.001) Earlier meta-analyses raised concerns about worsening renal function, though ASCEND-HF did not confirm this

Contraindications: Cardiogenic shock or systolic BP <90 mmHg; Known hypersensitivity to nesiritide or any of its components; Should not be used as primary therapy for diuresis

Peptide Tools

Reconstitution CalculatorCalculate concentration and syringe units for any peptide vial with visual syringe guide.

Dosage & Cycle PlannerPlan a multi-week peptide cycle. Calculate total supply needed and vial counts.

Bacteriostatic Water CalculatorCalculate how many vials of bacteriostatic water you need for your peptide stack.

Cost-Per-Milligram CalculatorCompare vendors side-by-side. Find the best value per milligram and per dose.

Frequently Asked Questions

Related Resources

Browse All Research Peptides

Explore More

Nesiritide Dosing Guide Peptides for Acute Heart Failure Peptides for Hemodynamic Support

Research Use Only. The information on this page is compiled from published research literature and is provided for educational purposes only. It does not constitute medical advice. All compounds referenced are intended for in vitro research use by qualified laboratories and institutions.